Grines, Cindy L |
AGENT IDE, NCT06492174: A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort |
|
|
| Active, not recruiting | 3 | 20 | US | AGENT DCB 40 mm | Boston Scientific Corporation | In-Stent Restenosis | 12/25 | 12/27 | | |
DTU-STEMI, NCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: the STEMI-DTU Trial |
|
|
| Active, not recruiting | N/A | 527 | Europe, Canada, US | Impella CP® placement prior to reperfusion with Primary PCI | Abiomed Inc. | ST Elevation (STEMI) Myocardial Infarction of Anterior Wall | 09/24 | 10/30 | | |
NCT05412927: AngelMed Guardian® System PMA Post Approval Study |
|
|
| Recruiting | N/A | 500 | US | PMA P150009 AngelMed Guardian® System | Angel Medical Systems | Acute Coronary Syndrome | 12/26 | 12/26 | | |
Nasur, Ali |
NCT03970343: Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy |
|
|
| Recruiting | N/A | 620 | US | OPTIMIZER Smart System | Impulse Dynamics | Heart Failure | 03/26 | 03/26 | | |
NCT05412927: AngelMed Guardian® System PMA Post Approval Study |
|
|
| Recruiting | N/A | 500 | US | PMA P150009 AngelMed Guardian® System | Angel Medical Systems | Acute Coronary Syndrome | 12/26 | 12/26 | | |
Willis, Christy |
NCT03970343: Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy |
|
|
| Recruiting | N/A | 620 | US | OPTIMIZER Smart System | Impulse Dynamics | Heart Failure | 03/26 | 03/26 | | |
NCT05412927: AngelMed Guardian® System PMA Post Approval Study |
|
|
| Recruiting | N/A | 500 | US | PMA P150009 AngelMed Guardian® System | Angel Medical Systems | Acute Coronary Syndrome | 12/26 | 12/26 | | |